This topic contains a solution. Click here to go to the answer

Author Question: What defines the bargaining zone in a negotiation? How does a positive or negative bargaining zone ... (Read 149 times)

cookcarl

  • Hero Member
  • *****
  • Posts: 539
What defines the bargaining zone in a negotiation? How does a positive or negative bargaining zone affect
  the outcome of a negotiation?
 
  What will be an ideal response?

Question 2

External equity refers to how fair the job's pay rate is when compared to other jobs within the same company.
 
  Indicate whether this statement is true or false.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

livaneabi

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

The bargaining zone is the range between negotiators' reservation points. A positive bargaining zone means that
mutual agreement is better than resorting to BATNAs. A negative bargaining zone indicates there is no positive
overlap between the parties' reservation points, and negotiators should not waste time negotiating but should
exercise their BATNAs instead.

Answer to Question 2

Answer: FALSE




cookcarl

  • Member
  • Posts: 539
Reply 2 on: Jul 7, 2018
:D TYSM


bigcheese9

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library